Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / American Depositary Shares
-
Shares outstanding
-
60.8M
-
Number of holders
-
219
-
Total shares
-
62.6M
-
Shares change
-
+1.34M
-
Total reported value, excl. options
-
$9.31B
-
Value change
-
+$237M
-
Put/Call ratio
-
1.51
-
Number of buys
-
117
-
Number of sells
-
-93
-
Price
-
$149.31
Significant Holders of Ascendis Pharma A/S - American Depositary Shares (ASND)
filings reported holding ASND - Ascendis Pharma A/S - American Depositary Shares as of Q3 2024.
Ascendis Pharma A/S - American Depositary Shares (ASND) has 219 institutional owners and holders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.6M shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (9.71M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (5.13M shares), Avoro Capital Advisors LLC (4.99M shares), FMR LLC (4.91M shares), Artisan Partners Limited Partnership (4.41M shares), JANUS HENDERSON GROUP PLC (4.19M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.12M shares), Capital International Investors (2.11M shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (1.87M shares), and T. Rowe Price Investment Management, Inc. (1.77M shares).
This table shows the top 219 institutional owners of the company. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.